MENARINI is a fully integrated privately owned pharma company with a long and successful heritage in strategic partnering across the globe. We have a profound know-how stemming from our strong R&D capabilities in key therapeutic areas, coupled with our excellence in commercial execution and our powerful direct presence on a global basis.
Respiratory & Allergology
Menarini group is excited to announce our participation in the upcoming Respiratory Effectiveness Group (REG) Summit 2025, taking place from March 20-22 at the Royal College of Physicians in London, UK.
The REG Summit is the premier event in the field of real-life research in Respiratory and Allergy medicine. Internationally renowned opinion leaders will interact and debate the latest topics and cutting-edge developments through a variety of interactive and informative sessions.
We’re proud to support this distinguished event and look forward to contributing to the advancement of both respiratory and allergy care.


Respiratory
Respiratory diseases are not and must not be diseases with no way out. Menarini's commitment in respiratory therapeutic area has...

Allergology
Allergies are an abnormal and specific reaction of the immune system to harmless substances in the environment, called allergens...
The impact of Allergies in patients’ life
“Allergic diseases constitute a significant cause of morbidity worldwide and have an important impact on the general state of well-being of people affected.
The vast majority of allergic patients are insufficiently treated, and this condition contributes in reducing the Quality of Life, the ability to learn and to carry out normal daily activities as well as in impacting the socioeconomic burden in terms of absence from work and decreased productivity.”